BERKELEY, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced new preclinical data ...

I’m addicted to my phone. Wow, it feels good to say it! This uncomfortable truth sharpened recently when a friend shared her pet peeve about cell phones on the table when dining out with companions.

In a new study published in Nature Communications titled, “The reference genome of the human diploid cell line RPE-1,” researchers from University of Rome La Sapienza have produced the first reference ...

Gilead Sciences broke into the field of cancer cell therapies through an acquisition. Now it’s aiming to be part of the next generation of such therapies by buying clinical-stage Interius ...

The new ‘COPILOT’ function uses AI to generate summaries, tags, tables, and more based on a group of cells. The new ‘COPILOT’ function uses AI to generate summaries, tags, tables, and more based on a ...

Alana M. Staniszewski of Marshall Dennehey. Courtesy photo.. On May 30, 2025, the Pennsylvania Supreme Court issued a landmark decision, overturning years of precedent regarding a claimant’s ...

Data wonks, rejoice! Pivot tables now automatically refresh themselves in a new beta version of Microsoft Excel. You might expect that pivot tables—which can be used to summarize rows and columns of ...

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...